Depression, Anxiety and Stress in High School

Sponsor
Instituto Mexicano del Seguro Social (Other)
Overall Status
Completed
CT.gov ID
NCT05190107
Collaborator
(none)
3,112
1
7.3
424.8

Study Details

Study Description

Brief Summary

Background: Social isolation secondary to the pandemic can predispose the population to mental health issues in the future, especially teenagers. The Depression, Anxiety, and Stress Scale (DASS) is a valuable self-report scale since it may be used to screen for anxiety, depression, and stress in one questionnaire. In the last years, it has been observed effective in detecting these symptoms in teenagers.

Aims: Identify the prevalence of depression, anxiety, and stress in high school students during the COVID-19 pandemic This is an observational cross-sectional study.

For this study, the validated Spanish version of DASS-21 will be used. Qualitative variables will be evaluated through central tendencies, such as mean, standard deviation, and frequencies. The inferential analysis of categorical variables will be performed using the chi-squared test, analysis of variance (ANOVA), or Kruskal Wallis test as appropriate. For quantitative variables, Student's t-test or Mann Whitney U test will be performed depending on their distribution.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: DASS-21 scale

Study Design

Study Type:
Observational
Actual Enrollment :
3112 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Prevalence of Depression, Anxiety and Stress in High School Students: A Survey Study in Western Mexico
Actual Study Start Date :
May 1, 2021
Actual Primary Completion Date :
Nov 1, 2021
Actual Study Completion Date :
Dec 10, 2021

Outcome Measures

Primary Outcome Measures

  1. Depression Score [Baseline]

    the Depression, Anxiety and Stress Scale 21 (DASS-21) is an inventory that will be used to identify the presence and intensity of depressive, anxiety and stress. For depression the cutoff scores are: Normal: 0-9, Mild: 10-12, Moderate:13-20, Severe: 21-27, and Extremely severe: 28-42.

  2. Anxiety Score [Baseline]

    the Depression, Anxiety and Stress Scale 21 (DASS-21) is an inventory that will be used to identify the presence and intensity of depressive, anxiety and stress. For anxiety the cutoff scores are: Normal: 0-6, Mild: 7-9, Moderate: 10-14, Severe:15-19, and Extremely severe: 20-42.

  3. Stress Score [Baseline]

    the Depression, Anxiety and Stress Scale 21 (DASS-21) is an inventory that will be used to identify the presence and intensity of depressive, anxiety and stress. For stress the cutoff scores are: Normal: 0-10, Mild:11-18, Moderate:19-26, Severe: 27-34, and Extremely severe: 35-42.

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 22 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adolescents from 14 to 22 years old.

  • That they voluntarily agree to participate, and consent.

Exclusion Criteria:
  • Adolescents with depression, anxiety, and stress disorders previously detected

  • Patients in psychiatric treatment for depression, anxiety, or stress.

  • Participants who don´t consent to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centro Médico Nacional de Occidente Guadalajara Jalisco Mexico 44329

Sponsors and Collaborators

  • Instituto Mexicano del Seguro Social

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
GONZALEZ-OJEDA ALEJANDRO, Principal Investigator D, Instituto Mexicano del Seguro Social
ClinicalTrials.gov Identifier:
NCT05190107
Other Study ID Numbers:
  • DASSH
First Posted:
Jan 13, 2022
Last Update Posted:
Jan 13, 2022
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 13, 2022